- Home
- HUBC vs ERNA Comparison
HUBC vs ERNA Comparison
Compare HUBC & ERNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUBC
- ERNA
- Stock Information
- Founded
- HUBC 2017
- ERNA 2018
- Country
- HUBC Israel
- ERNA United States
- Employees
- HUBC N/A
- ERNA N/A
- Industry
- HUBC
- ERNA Biotechnology: Pharmaceutical Preparations
- Sector
- HUBC
- ERNA Health Care
- Exchange
- HUBC Nasdaq
- ERNA Nasdaq
- Market Cap
- HUBC N/A
- ERNA 14.5M
- IPO Year
- HUBC N/A
- ERNA N/A
- Fundamental
- Price
- HUBC $3.14
- ERNA $0.18
- Analyst Decision
- HUBC
- ERNA
- Analyst Count
- HUBC 0
- ERNA 0
- Target Price
- HUBC N/A
- ERNA N/A
- AVG Volume (30 Days)
- HUBC 155.1K
- ERNA 180.2K
- Earning Date
- HUBC 12-13-2024
- ERNA 05-13-2025
- Dividend Yield
- HUBC N/A
- ERNA N/A
- EPS Growth
- HUBC N/A
- ERNA N/A
- EPS
- HUBC N/A
- ERNA N/A
- Revenue
- HUBC $33,357,000.00
- ERNA $582,000.00
- Revenue This Year
- HUBC N/A
- ERNA N/A
- Revenue Next Year
- HUBC N/A
- ERNA N/A
- P/E Ratio
- HUBC N/A
- ERNA N/A
- Revenue Growth
- HUBC N/A
- ERNA 755.88
- 52 Week Low
- HUBC $2.65
- ERNA $0.16
- 52 Week High
- HUBC $21.70
- ERNA $2.63
- Technical
- Relative Strength Index (RSI)
- HUBC 35.15
- ERNA 28.85
- Support Level
- HUBC $2.65
- ERNA $0.16
- Resistance Level
- HUBC $3.72
- ERNA $0.20
- Average True Range (ATR)
- HUBC 0.74
- ERNA 0.03
- MACD
- HUBC -0.11
- ERNA -0.01
- Stochastic Oscillator
- HUBC 12.97
- ERNA 12.75
About ERNA Eterna Therapeutics Inc.
Eterna Therapeutics Inc is a biopharmaceuticals company. The company develops transformational new medicines using various cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs.